Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.
#1000 most reported symptom for this vaccine
Oral mucosal eruption has been reported 14 times in association with Influenza, Seasonal (Flulaval Quadrivalent) vaccination in VAERS. This represents 0.0% of all 52,111 reports for this vaccine.
Among these reports, 0 mentioned death (0.00%) and 1 involved hospitalization (7.1%).
Oral mucosal eruption is the #1000 most frequently reported symptom for Influenza, Seasonal (Flulaval Quadrivalent) out of 2354 total symptoms.
Disclaimer: VAERS reports describe events that occurred after vaccination but do not establish that the vaccine caused the event. Many reported symptoms may be coincidental or related to underlying conditions.
Seeing 14 reports of Oral mucosal eruption after Influenza, Seasonal (Flulaval Quadrivalent) vaccination may seem alarming, but context is critical.
The mortality rate among these reports is very low at 0.00%, suggesting most cases are non-fatal.
This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.